-
1
المؤلفون: Hunter, S. F., Aburashed, R. A., Alroughani, R., Chan, A. N., Dive, D., Eichau, S., Kantor, D., Kim, H. J., Lycke, Jan, 1956, Macdonell, R. A. L., Pozzilli, C., Scott, T., Sharrack, B., Wiendl, H., Chung, L. K., Daizadeh, N., Baker, D. P., Vermersch, P., Care-Ms, I. Care-Ms Ii Camms To
المصدر: Neurology and Therapy. 10:803-818
مصطلحات موضوعية: Clinical Medicine, Klinisk medicin
URL الوصول: https://gup.ub.gu.se/publication/308624
-
2
المؤلفون: Darren P Baker, Carlos Navas, Carolina Ionete, Mar Tintoré, Zia Choudhry, Rafael Arroyo, David Rog, Nadia Daizadeh, Aaron Boster, Bernard M. J. Uitdehaag, Sara Eichau, Lívia Sousa, Topaz investigators, Jennifer Ravenscroft, Volker Limmroth, Carlo Pozzilli, Alexey Boyko, Ann D Bass, Care-Ms I, Care-Ms Ii, Camms, Daniel Pelletier
المساهمون: Neurology, Amsterdam Neuroscience - Neuroinfection & -inflammation, Institut Català de la Salut, [Bass AD] Neurology Center of San Antonio, San Antonio, TX, USA. [Arroyo R] Hospital Universitario Quirónsalud Madrid (RA), Pozuelo de Alarcón, Madrid, Spain. [Boster AL] Boster MS Center, Columbus, OH, USA. [Boyko AN] Pirogov Russian National Research University, Department of Neuroimmunology of the Federal Center of Brain and Neurosciences, Moscow, Russia. [Eichau S] Hospital Universitario Virgen Macarena, Seville, Spain. [Ionete C] University of Massachusetts Memorial Medical Center, Worcester, MA, USA. [Tintoré M] Vall d'Hebron Hospital Universitari, Barcelona, Spain, Vall d'Hebron Barcelona Hospital Campus
المصدر: Multiple Sclerosis and Related Disorders, 49:102717. Elsevier
Scientia
Bass, A D, Arroyo, R, Boster, A L, Boyko, A N, Eichau, S, Ionete, C, Limmroth, V, Navas, C, Pelletier, D, Pozzilli, C, Ravenscroft, J, Sousa, L, Tintoré, M, Uitdehaag, B M J, Baker, D P, Daizadeh, N, Choudhry, Z, Rog, D & CARE-MS I, CARE-MS II, CAMMS03409, and TOPAZ investigators 2021, ' Alemtuzumab outcomes by age : Post hoc analysis from the randomized CARE-MS studies over 8 years ', Multiple Sclerosis and Related Disorders, vol. 49, 102717 . https://doi.org/10.1016/j.msard.2020.102717مصطلحات موضوعية: medicine.medical_specialty, Efficacy, Disease, Other subheadings::Other subheadings::/drug therapy [Other subheadings], Antibodies, Monoclonal, Humanized, 03 medical and health sciences, 0302 clinical medicine, Age, Multiple Sclerosis, Relapsing-Remitting, Age groups, Long-term, Diagnosis::Diagnostic Techniques and Procedures::Diagnostic Imaging::Tomography::Magnetic Resonance Imaging [ANALYTICAL, DIAGNOSTIC AND THERAPEUTIC TECHNIQUES, AND EQUIPMENT], Internal medicine, Post-hoc analysis, medicine, Humans, diagnóstico::técnicas y procedimientos diagnósticos::diagnóstico por imagen::tomografía::imagen por resonancia magnética [TÉCNICAS Y EQUIPOS ANALÍTICOS, DIAGNÓSTICOS Y TERAPÉUTICOS], Treatment effect, 030212 general & internal medicine, Child, Esclerosi múltiple - Imatgeria per ressonància magnètica, Alemtuzumab, business.industry, Multiple sclerosis, Nervous System Diseases::Autoimmune Diseases of the Nervous System::Demyelinating Autoimmune Diseases, CNS::Multiple Sclerosis [DISEASES], diagnóstico::pronóstico::resultado del tratamiento [TÉCNICAS Y EQUIPOS ANALÍTICOS, DIAGNÓSTICOS Y TERAPÉUTICOS], Age cohorts, General Medicine, Middle Aged, Diagnosis::Prognosis::Treatment Outcome [ANALYTICAL, DIAGNOSTIC AND THERAPEUTIC TECHNIQUES, AND EQUIPMENT], medicine.disease, Brain volume loss, Treatment Outcome, Neurology, enfermedades del sistema nervioso::enfermedades autoinmunitarias del sistema nervioso::enfermedades autoinmunes desmielinizantes del SNC::esclerosis múltiple [ENFERMEDADES], Avaluació de resultats (Assistència sanitària), Safety, Neurology (clinical), business, Esclerosi múltiple - Tractament, 030217 neurology & neurosurgery, Interferon beta-1a, medicine.drug
وصف الملف: application/pdf
-
3
المؤلفون: Topaz investigators, Christopher LaGanke, Samuel F. Hunter, Zia Choudhry, Tjalf Ziemssen, Giancarlo Comi, Bart Van Wijmeersch, Daniel Pelletier, Ann D Bass, Sven Schippling, Care-Ms I, Care-Ms Ii, Camms, Lívia Sousa, Anthony Traboulsee, Regina Berkovich, Volker Limmroth, Carlo Pozzilli, Barry A Singer, Bernard M. J. Uitdehaag, Sara Eichau, Jeremy Hobart, Nadia Daizadeh
المساهمون: Ziemssen, Tjalf/0000-0001-8799-8202, Neurology, Amsterdam Neuroscience - Neuroinfection & -inflammation
المصدر: CNS Drugs
Ziemssen, T, Bass, A D, Berkovich, R, Comi, G, Eichau, S, Hobart, J, Hunter, S F, LaGanke, C, Limmroth, V, Pelletier, D, Pozzilli, C, Schippling, S, Sousa, L, Traboulsee, A, Uitdehaag, B M J, Van Wijmeersch, B, Choudhry, Z, Daizadeh, N, Singer, B A & CARE-MS I, CARE-MS II, CAMMS03409, and TOPAZ investigators 2020, ' Efficacy and Safety of Alemtuzumab Through 9 Years of Follow-up in Patients with Highly Active Disease : Post Hoc Analysis of CARE-MS I and II Patients in the TOPAZ Extension Study ', CNS Drugs, vol. 34, no. 9, pp. 973-988 . https://doi.org/10.1007/s40263-020-00749-x
CNS Drugs, 34(9), 973-988. Adis International Ltdمصطلحات موضوعية: Adult, Male, medicine.medical_specialty, Neurology, Population, Outcomes, multiple sclerosis, 03 medical and health sciences, Young Adult, 0302 clinical medicine, Pharmacotherapy, Multiple Sclerosis, Relapsing-Remitting, No Evidence, Internal medicine, Post-hoc analysis, medicine, Humans, Immunologic Factors, Pharmacology (medical), Original Research Article, education, Adverse effect, Alemtuzumab, clinical trials, education.field_of_study, Disability, Expanded Disability Status Scale, business.industry, Aggressive Multiple-Sclerosis, Multiple sclerosis, Fingolimod, medicine.disease, Magnetic Resonance Imaging, Highly Active Disease, 030227 psychiatry, Psychiatry and Mental health, Treatment Outcome, Female, Cell, Neurology (clinical), business, 030217 neurology & neurosurgery, Interferon beta-1a, multiple sclerosis, alemtuzumab, clinical trials, adult, Highly Active Disease, medicine.drug, Follow-Up Studies
وصف الملف: application/pdf
-
4
المؤلفون: Topaz investigators, Colin Mitchell, Elisabeth Gulowsen Celius, Stephen G Vincent, Renata Simm, Luke Chung, George J. Hutton, Anat Achiron, Camms , Care-Ms I, Care-Ms Ii, Camms, Jean-Raphael Schneider, David Rog, Marie Moore, Christina D. Chambers, Joy Derwenskus, Nadia Daizadeh, Pamela A. McCombe, Kerstin Hellwig, Virginia Devonshire, Lívia Sousa, Jiwon Oh, D Alastair S Compston
مصطلحات موضوعية: Adult, medicine.medical_specialty, Population, Abortion, 03 medical and health sciences, 0302 clinical medicine, Antineoplastic Agents, Immunological, Multiple Sclerosis, Relapsing-Remitting, Pregnancy, Recurrence, medicine, Humans, Lactation, 030212 general & internal medicine, education, Adverse effect, Alemtuzumab, education.field_of_study, Fetus, business.industry, Obstetrics, Multiple sclerosis, Thyroid, Pregnancy Outcome, General Medicine, medicine.disease, Abortion, Spontaneous, medicine.anatomical_structure, Neurology, Female, Neurology (clinical), business, 030217 neurology & neurosurgery, medicine.drug
Find this article in full text from Springer Verlag. 
Full Text via ClinicalKey